Crossmark

Prognostic implications of tissue-based homologous recombination deficiency in metastatic gastric cancer treated with immune checkpoint inhibitor plus chemotherapy

Crossref DOI link: https://doi.org/10.1007/s10120-026-01755-6

Published Online: 2026-05-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Changgon https://orcid.org/0000-0002-5759-727X
Kim, Junkyu

Shin, Ji Eun

Lim, Sung Hee

Kim, Kyoung-Mee

Kim, Deok Geun

Lee, Jeeyun

Kim, Seung Tae
Funding

Funding for this research was provided by:

Korea Health Industry Development Institute (RS-2025-02292969)
License Information

Text and Data Mining valid from 2026-05-22

Version of Record valid from 2026-05-22
More Information

Article History

Received: 1 December 2025

Accepted: 29 April 2026

First Online: 22 May 2026

Declarations

:

: The authors are fully responsible for the content of this manuscript, and the views and opinions described in this publication are solely those of the authors.

: This study was approved by the Institutional Review Board of Samsung Medical Center (approval number: [IRB NO. 2025-09-044-002]).

Document is current

Any future updates will be listed below